Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Yu Hua Zhao | M | 56 | 22 years | |
| Erwan Mao | M | 61 | 21 years | |
| Zhi Qiang Gong | M | 52 | 15 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Wing Cheong Leung | M | 63 | 9 years | |
| Qian Ru Huang | F | 71 | - | |
| Xiang Gao Zeng | M | 65 | 4 years | |
| Ajis Chandra | M | 60 |
University of Wollongong
| 6 years |
| Sin Yue Wong | F | 72 | 17 years | |
| Yu Jie Liu | F | 60 | 2 years | |
| Hua Cheng Wang | M | 61 | 3 years | |
| Charles C. Mo | M | 72 |
Benda Pharmaceutical, Inc.
 Benda Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Benda Pharmaceutical, Inc. is a pharmaceutical company, which engages in the development and manufacture of conventional medications and manufacture both conventional medicines and traditional Chinese medicines (TCM) for the treatment of common ailment and disease. It also engages in the development, manufacturing and commercialization of gene therapy products. The company was founded on February 17, 1982 and is headquartered in Wuhan, China. | 1 years |
| Zhe Xu | M | 54 | 6 years | |
| Hui Elizabeth Zhou | F | 60 |
University of Wollongong
| 1 years |
| Kai Wong | M | 53 |
University of Wollongong
| 4 years |
| Lee Lee Chui | F | - |
University of Wollongong
| 4 years |
| Hong Bing He | M | 51 | 3 years | |
| Jun Xiao | M | 47 | - | |
| Djunyanto Thriyana | M | 64 |
University of Wollongong
| 4 years |
| Ching Fan Koo | F | 55 | - | |
| Man Kit Tse | M | 50 |
University of Wollongong
| 4 years |
| Wai Leung Au | M | 56 |
University of Wollongong
| 4 years |
| Victor Emanuel Gomes | M | - |
University of Wollongong
| 4 years |
| Chang Gui Duan | M | 87 | - | |
| Kai Hua Zhang | F | 50 | - | |
| Qi Yuan Ma | M | 67 |
Benda Pharmaceutical, Inc.
Benda Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Benda Pharmaceutical, Inc. is a pharmaceutical company, which engages in the development and manufacture of conventional medications and manufacture both conventional medicines and traditional Chinese medicines (TCM) for the treatment of common ailment and disease. It also engages in the development, manufacturing and commercialization of gene therapy products. The company was founded on February 17, 1982 and is headquartered in Wuhan, China. | - |
| Billy Tung | M | - |
University of Wollongong
| 4 years |
| Eric de Rooy | M | - |
University of Wollongong
| 2 years |
| Jun Cao | M | 53 | 2 years | |
| Po Chak Chan | M | 57 |
University of Wollongong
| 1 years |
| Abdul Razak Saim | M | 55 |
University of Wollongong
| 4 years |
| Kin Wah Chan | M | 53 |
University of Wollongong
| 4 years |
| Djoko Wintoro | M | 71 |
University of Wollongong
| 1 years |
| Puan Aziah binti Ahmad | F | 56 |
University of Wollongong
| 4 years |
| Olive Tai | F | 49 |
University of Wollongong
| 4 years |
| Palakom Chaikittisilpa | M | 57 |
University of Wollongong
| 1 years |
| Yong Heng Low | M | 54 |
University of Wollongong
| 4 years |
| Jhoni Ginting | M | 62 |
University of Wollongong
| 3 years |
| Sabri Hussein | M | 58 |
University of Wollongong
| 4 years |
| Suwardi Ngaturi | M | 58 |
University of Wollongong
| 4 years |
| Faiz Achmad | M | 69 |
University of Wollongong
| 3 years |
| Yuan Jun Gao | F | 68 | 3 years | |
| Min Ji Li | M | 59 | 7 years | |
| Zhi Li | F | 47 | 3 years | |
| Ho Yin Fok | M | 53 |
University of Wollongong
| 4 years |
| John Micek | M | 71 |
Benda Pharmaceutical, Inc.
Benda Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Benda Pharmaceutical, Inc. is a pharmaceutical company, which engages in the development and manufacture of conventional medications and manufacture both conventional medicines and traditional Chinese medicines (TCM) for the treatment of common ailment and disease. It also engages in the development, manufacturing and commercialization of gene therapy products. The company was founded on February 17, 1982 and is headquartered in Wuhan, China. | 2 years |
| Ying Xu | M | 61 | 10 years | |
| Xiao Yun Li | M | 67 | 10 years | |
| Wen Liang Wang | M | 53 | - | |
| Ming Ban Tan | M | 53 |
University of Wollongong
| 4 years |
| Beng Hong Tan | F | 52 |
University of Wollongong
| 4 years |
| Rong Hong Zhou | M | 61 |
Benda Pharmaceutical, Inc.
Benda Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Benda Pharmaceutical, Inc. is a pharmaceutical company, which engages in the development and manufacture of conventional medications and manufacture both conventional medicines and traditional Chinese medicines (TCM) for the treatment of common ailment and disease. It also engages in the development, manufacturing and commercialization of gene therapy products. The company was founded on February 17, 1982 and is headquartered in Wuhan, China. | 1 years |
| Huilian Song | F | - |
Benda Pharmaceutical, Inc.
Benda Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Benda Pharmaceutical, Inc. is a pharmaceutical company, which engages in the development and manufacture of conventional medications and manufacture both conventional medicines and traditional Chinese medicines (TCM) for the treatment of common ailment and disease. It also engages in the development, manufacturing and commercialization of gene therapy products. The company was founded on February 17, 1982 and is headquartered in Wuhan, China. | - |
| Heng Fai Chan | M | 79 | 5 years | |
| Mohamed Farid bin Nawawi | M | 58 |
University of Wollongong
| 4 years |
| Hai Lin Ge | M | - |
University of Wollongong
| 3 years |
| Chin Guan Pheng | M | 53 |
University of Wollongong
| 4 years |
| Craig Peden | M | - |
University of Wollongong
| 4 years |
| Jun Tang | M | 61 |
Benda Pharmaceutical, Inc.
Benda Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Benda Pharmaceutical, Inc. is a pharmaceutical company, which engages in the development and manufacture of conventional medications and manufacture both conventional medicines and traditional Chinese medicines (TCM) for the treatment of common ailment and disease. It also engages in the development, manufacturing and commercialization of gene therapy products. The company was founded on February 17, 1982 and is headquartered in Wuhan, China. | 2 years |
| Jing Sun | F | 50 | 2 years | |
| Himawan Turatmo | M | 71 |
University of Wollongong
| 1 years |
| Tsz Fung Lo | M | 57 |
University of Wollongong
| 4 years |
| Lachlan Hughes | M | - |
University of Wollongong
| 4 years |
| Yan Tung Yang | F | 54 | 9 years | |
| Ka Wai Lo | M | 54 |
University of Wollongong
| 4 years |
| Hong Yin Shi | M | 56 | - | |
| Chun Wa Tam | M | 61 |
University of Wollongong
| 4 years |
| Pat Kelly | M | - |
University of Wollongong
| 4 years |
| Jian Feng Cui | M | 51 |
University of Wollongong
| 4 years |
| Troy Gill | M | 53 |
University of Wollongong
| 4 years |
| Hongky Jeffry Nantung | M | 61 |
University of Wollongong
| 4 years |
| Greg W. Kilby | M | - |
University of Wollongong
| 3 years |
| Kan Chun Tsui | M | 51 |
University of Wollongong
| 4 years |
| Cheuk Kwong Lo | M | 60 |
University of Wollongong
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Australia | 41 | 56.16% |
| China | 19 | 26.03% |
| Bermuda | 13 | 17.81% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Tak Shing Yu
- Personal Network
